Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

NCT07035067 is registered in ClinicalTrials.gov with PeriPharm as lead sponsor.

NCT NCT07035067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
Lead sponsor
PeriPharm
Phase
Observational
Overall status
Terminated
Start date
July 15, 2025
Completion date
April 1, 2026
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caregiver burden, ovarian cancer, patient burden